RecruitingNCT05297331

Renal Stone Treatment Global Registry

A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Urinary Calculi - International Registry

Sponsor

Chinese University of Hong Kong

Enrollment

3,000 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

Urolithiasis

Summary

This is an international prospective data registry to assess the treatment outcomes and complications of different treatment approaches for different surgical treatment of urolithiasis.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a global registry study that collects information about how kidney stones are treated around the world. The goal is to better understand outcomes and improve treatment practices for people with kidney stones. You may be eligible if... - You are 18 years or older - You are receiving treatment for kidney stones You may NOT be eligible if... - You are unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(3)

Alice Ho Miu Ling Nethersole Hospital

Hong Kong, Hong Kong

Prince of Wales Hospital

Shatin, Hong Kong

North District Hospital

Sheung Shui, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05297331

Related Trials

PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones

NCT072727201 location

Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent

NCT072758791 location